Petros Pharmaceuticals raises ~$5.7M in registered direct offering led by largest shareholder

Petros Pharmaceuticals, Inc.

Offering of 3,323,616 shares at $1.715 per share; warrants for same number at same price, 5-year term.
Gross proceeds ~$5.7M; net proceeds ~$5.4M after fees; expected close Oct 18, 2021.
Proceeds will fund expansion of men's health platform and general corporate purposes.
Katalyst Securities served as financial advisor; advisory fee and expenses $235,000 plus 130,000 warrants.
Largest shareholder led the offering; warrants issued in private placement, unregistered.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.